Northern Trust Corp Pmv Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 87,150 shares of PMVP stock, worth $140,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,150

Previous 323,710 73.08%

Holding current value

$140,311

Previous $524,000 75.38%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.44 - $1.69 $340,646 - $399,786	-236,560 Reduced 73.08%	87,150 $129,000
Q2 2024 Aug 14, 2024	SELL	$1.51 - $2.21 $21,780 - $31,877	-14,424 Reduced 4.27%	323,710 $524,000
Q1 2024 May 14, 2024	BUY	$1.51 - $3.12 $16,474 - $34,039	10,910 Added 3.33%	338,134 $574,000
Q4 2023 Feb 13, 2024	SELL	$1.23 - $6.6 $15,381 - $82,533	-12,505 Reduced 3.68%	327,224 $1.01 Million
Q3 2023 Nov 13, 2023	BUY	$6.01 - $8.93 $113,775 - $169,053	18,931 Added 5.9%	339,729 $2.09 Million
Q2 2023 Aug 11, 2023	BUY	$3.94 - $6.27 $48,430 - $77,070	12,292 Added 3.98%	320,798 $2.01 Million
Q1 2023 May 15, 2023	SELL	$4.77 - $9.16 $58,322 - $111,999	-12,227 Reduced 3.81%	308,506 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$8.17 - $12.95 $34,436 - $54,584	4,215 Added 1.33%	320,733 $2.79 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $38,543 - $58,085	3,381 Added 1.08%	316,518 $3.77 Million
Q2 2022 Aug 12, 2022	BUY	$9.23 - $22.43 $621,908 - $1.51 Million	67,379 Added 27.42%	313,137 $4.46 Million
Q1 2022 May 13, 2022	SELL	$14.86 - $23.55 $52,530 - $83,249	-3,535 Reduced 1.42%	245,758 $5.12 Million
Q4 2021 Feb 08, 2022	SELL	$19.99 - $30.24 $75,622 - $114,397	-3,783 Reduced 1.49%	249,293 $5.76 Million
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $172,822 - $235,538	-6,439 Reduced 2.48%	253,076 $7.54 Million
Q2 2021 Aug 13, 2021	BUY	$28.01 - $36.01 $2.74 Million - $3.52 Million	97,688 Added 60.37%	259,515 $8.87 Million
Q1 2021 May 12, 2021	BUY	$30.66 - $49.5 $170,132 - $274,675	5,549 Added 3.55%	161,827 $5.32 Million
Q4 2020 Feb 11, 2021	BUY	$31.86 - $61.51 $4.47 Million - $8.63 Million	140,300 Added 878.08%	156,278 $9.61 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $567,219 - $607,164	15,978 New	15,978 $567,000

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Pmv Pharmaceuticals, Inc. Transaction History